Healthcare Costs
-
Caught my eye, Copay Accumulators, Drug Prices, Employers, Healthcare Costs, Insulin, Medicare Part D, Pharmacy Benefit Managers, Utilization ManagementAMP is WAC — 2/6/26
Read more: AMP is WAC — 2/6/26No, I do not think that a groundhog is a meteorologist. But, one year I am determined to make it to see Punxsutawney Phil. I expect it to be silly and cold and over quickly. I will likely have to go solo because my family thinks getting a bus from a Wal-mart parking lot in…
-
340B, Caught my eye, CMMI, Drug Prices, FDA, Healthcare Costs, Inflation Reduction Act, Medicare Advantage, Medicare Negotiation, Medicare Part D, Orphan Drugs, Pharmacy Benefit Managers, Reference Pricing, ValueAMP is WAC — 1/16/26
Read more: AMP is WAC — 1/16/26In case you thought I’d leaving you hanging, today’s newsletter has a summary on GLOBE. Sphere it below? Calling it a Plan would be GENEROUS, but that’s a Whole Other Thing. On Thursday, the White House released a fact sheet urging Congress to enact President Trump’s “Great Healthcare Plan,” pitching it as a cost-cutting package…
-
340B, Affordable Care Act, Caught my eye, CMMI, Drug Prices, Healthcare Costs, ICER, Medicare Part D, Pharmacy Benefit Managers, Reference Pricing, State-based Reform, Utilization ManagementAMP is WAC — 12/19/25
Read more: AMP is WAC — 12/19/25Today we’re expecting to hear more about manufacturer Most Favored Nation (MFN) agreements and (if you trust the rumors) maybe more about the MFN demos – the Global Benchmark for Efficient Drug Pricing (GLOBE) Model and the Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model. I wasn’t planning on publishing the next two weeks,…
-
340B, Alzheimer’s, Caught my eye, FDA, Healthcare Costs, Inflation Reduction Act, Medicare Negotiation, Preventative, Reference Pricing, ValueAMP is WAC — 12/12/25
Read more: AMP is WAC — 12/12/25Much of this week felt like playing catch-up from past weeks. Good timing because rumors are swirling about Most Favored Nation (MFN) demonstration releases for late next week. Comment letter fun during the holidays! For those of you who are new to these parts… welcome! I’m a health policy strategist focused on pharmaceuticals. My goal…
-
Affordable Care Act, Caught my eye, Employers, Healthcare Costs, Medicaid, Medicare Part D, Pharmacy Benefit Managers, Reference Pricing, State-based Reform, Utilization ManagementAMP is WAC — 9/19/25
Read more: AMP is WAC — 9/19/25Work travel is usually a nice change of pace. And then I found myself on a Wednesday afternoon on the NJ Turnpike in torrential rain with other cars facing the wrong direction. Super fun! Two good things – 1) the pharma team I gave the talk to was awesome and 2) made it home safe…
-
AMP is WAC — 7/10/25
Read more: AMP is WAC — 7/10/25Last Saturday I was in the customs line in Amsterdam and the agent smirked and said, “Big Beautiful Bill, huh?” I wanted to say something, but I was mostly impressed that he was following U.S. news more closely than a lot of Americans. Caught my Eye 340No. IQVIA released a study looking at the use…
-
Affordable Care Act, Biosimilars, Caught my eye, Employers, Healthcare Costs, Inflation Reduction Act, Medicare Advantage, Medicare Part D, Pharmacy Benefit Managers, Utilization ManagementAMP is WAC — 6/27/25
Read more: AMP is WAC — 6/27/25In case you think I’m opinionated, just know that it could be so.much.worse. I often write something and then hit backspace, backspace, backspace. You’re welcome? Off next week for the 4th of July. Caught my Eye Tradeoffs. Last week USC put out a paper that reviewed how many Medicare Part D beneficiaries will likely pay…
-
AMP is WAC — 06/06/25
Read more: AMP is WAC — 06/06/25I love this time of year, it feels nostalgic. All sorts of changes are going on with students graduating or changing schools with the hum of music and the whiff of sunscreen ever present in the background. Or maybe I just long for simpler times? Caught my Eye Waiting Game. This week the Department of…
-
340B, Alzheimer’s, Biosimilars, Caught my eye, Drug Prices, Generics, Healthcare Costs, Importation, Medicaid, State-based ReformAMP is WAC — 05/23/25
Read more: AMP is WAC — 05/23/25It’s the Friday of Memorial Day weekend, let’s blow this pop (pup?) stand. I’m playing with the format of these posts so let me know what you think. The aim is to be more of a newsletter than a blog, but still give you everything you need to know in just a few minutes a…
-
340B, Biosimilars, CMMI, Drug Prices, Generics, Healthcare Costs, Importation, Insulin, Medicaid, Pharmacy Benefit ManagersDon’t Call it a Comeback
Read more: Don’t Call it a ComebackLet’s wrap up my musings on the President’s Executive Order (EO). Medicaid. Section 6 of the EO directs the Office of Management and Budget (OMB) Director, the Assistant to the President for Domestic Policy, and the Assistant to the President for Economic Policy, in coordination with the Secretary of Health and Human Services (HHS), to…
Latest news
- AMP is WAC — 3/6/26
- AMP is WAC — 02/27/26
- AMP is WAC — 2/20/26
- AMP is WAC — 2/13/26
- AMP is WAC — 2/6/26
Categories
- 340B (62)
- Affordable Care Act (21)
- Alzheimer's (10)
- Biosimilars (31)
- Caught my eye (101)
- Cell and Gene (5)
- Chevron Deference (2)
- CMMI (26)
- Copay Accumulators (7)
- COVID (3)
- Drug Prices (55)
- Drug shortages (14)
- DTC (6)
- Employers (20)
- FDA (6)
- Generics (12)
- Health Equity (4)
- Healthcare Costs (39)
- Home Health (1)
- ICER (12)
- Importation (5)
- Inflation Reduction Act (67)
- Insulin (7)
- IP (3)
- Long term care (1)
- Medicaid (22)
- Medicare Advantage (27)
- Medicare Negotiation (68)
- Medicare Part D (76)
- Medicare Transaction Facilitator (5)
- Medicare Transaction Facilitator (12)
- Obesity (26)
- On the Horizon (1)
- Orphan Drugs (8)
- Pharmacy Benefit Managers (48)
- Preventative (5)
- Reference Pricing (26)
- State-based Reform (30)
- Supply Chain (7)
- Tariffs (1)
- Uncategorized (8)
- Utilization Management (11)
- Vaccines (9)
- Value (18)